S-1/A: Leef Brands Files Amendment to Registration Statement

Leef Brands updates its S-1 filing for proposed resale of common stock.

Summary

• Leef Brands, Inc. filed Amendment No. 1 to its Form S-1 registration statement.
• The filing relates to the proposed resale of up to ______________ shares of common stock by selling security holders.
• The shares consist of (i) _____________ shares outstanding and (ii) ________________ shares issuable upon exercise of purchase warrants.
• The company will not receive any proceeds from the sale of common stock by the selling security holders, but will receive the exercise price upon cash exercise of the Purchase Warrants.
• The selling security holders will bear all commissions and discounts, if any, attributable to the sale of the shares of common stock.
• The company will bear all costs, expenses and fees in connection with the registration of the shares of common stock.
• The selling security holders will offer and sell the shares at a fixed price of $x.xx per share until the common stock is listed on an established public trading market.
• The company is an emerging growth company and a smaller reporting company.

Sentiment

Score: 4

Explanation: The filing contains a mix of positive and negative elements, with a focus on risks and challenges. The financial results are not strong, and there is uncertainty about the future.

Positives

• LEEF received a 186.7 acre cultivation land use permit, which will result in it owning one of the largest cannabis cultivation site in the state of California.
• LEEF is a vertically integrated cannabis extraction and manufacturing operator based in California.
• LEEFs initial 65 acres of cultivation planted in 2025 on Salisbury Canyon Ranch mark a pivotal shiftallowing LEEF to grow its own biomass and reduce input costs by an estimated 4060%; full-scale cultivation is anticipated to reach 187 acres by 2027.
• In early 2025, it executed expansions across all three extraction linesethanol (+66%), solventless (+50%), and hydrocarbon (+38%).
• LEEFs revenue model centers on bulk B2B concentrate supply, providing extracted products to major brands across California and maintaining white-label agreements and cultivation partnerships with more than 250 farms.

Negatives

• The company has incurred net losses and cannot assure you that we will achieve or maintain profitable operations. Our net loss was $24.6 million for the year ended December 31, 2024, and $34.6 million for the year ended December 31, 2023.
• Overall revenue declined in 2024 as a result of significant price compression across the California cannabis market.
• Gross margins also decreased year-over-year due to lower average selling prices and competitive market dynamics.

Risks

• The price of our shares of common stock has been, and is likely to be, volatile, and you could lose all or part of your investment.
• There is a limited trading market for our common stock.
• We do not anticipate paying cash dividends, and accordingly, stockholders must rely on stock appreciation for any return on their investment.
• If securities or industry analysts do not publish research or reports or publish inaccurate or unfavorable research or reports about our business, our share price and trading volume could decline.
• We are an emerging growth company, and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our shares of common stock less attractive to investors.
• Raising additional capital, including through future sales and issuances of our common stock, or warrants could result in additional dilution of the percentage ownership of our stockholders, could cause our share price to fall and could restrict our operations.
• Our issuance of preferred shares could adversely affect the market value of our common shares.
• Indemnification of our officers and directors may result in substantial expenditures by us.
• Our reporting obligations will be limited under Section 15(d) of the Exchange Act, which may result in reduced transparency for investors.
• Cannabis continues to be a controlled substance under the CSA.
• U.S. state regulatory uncertainty may adversely impact the Company.
• The Company may be subject to applicable anti-money laundering laws and regulations.
• U.S. border officials could deny entry into the U.S. to employees of or investors in companies with cannabis operations in the United States.
• The Company may have difficulty accessing the services of banks, which may make it difficult to operate its business.
• The Company may have difficulty accessing public and private capital.
• The Company may lack access to U.S. bankruptcy protections.
• The Companys operations in the U.S. cannabis market may be subject to heightened scrutiny by regulatory authorities.
• The Company may be subject to the risk of civil asset forfeiture.
• The laws and regulations affecting the cannabis industry are constantly changing.
• There may be a restriction on deduction of certain expenses.
• There may be difficulty with the enforceability of contracts.
• The ability to grow a business with ties to cannabis operations in the United States depends on state laws pertaining to the cannabis industry.
• Political uncertainty may have an adverse impact on the Company s operating performance and results of operations.
• Unfavorable publicity or consumer perception may affect the success of the Company s business.
• Social media may impact the Company s reputation.
• Significant failure or deterioration of the Companys quality control systems may adversely impact the Company.
• Service providers could suspend or withdraw service, which could adversely affect the Company s business.
• The Company may be subject to product liability claims.
• The Company may be subject to product recalls.
• The Company is subject to risks inherent in an agricultural business.
• The Company may be vulnerable to rising energy costs.
• The Company is reliant on key inputs.
• The pricing of raw materials used in our products and some of our products can be extremely volatile, which may have a material adverse effect on our financial result.
• Results of future clinical research may negatively impact the cannabis industry.
• The Company faces competition from the illegal cannabis market.
• The Company may be subject to environmental regulations and risks.
• The Company may be subject to constraints on the marketing of its products.
• The Company may lack access to U.S. bankruptcy protections.
• The Company may be subject to the risks associated with fraudulent or illegal activity by its employees, contractors and consultants.
• The Company may be subject to risks related to information technology systems, including cyber-attacks.
• The Company may be subject to risks related to security breaches.
• The Companys operations may be affected by changes in the economic environment.
• Management of growth may prove to be difficult.
• The Company does not intend to pay dividends on the Common Shares, so any returns will be limited to increases, if any, in the value of the Common Shares.
• The Companys officers and directors may be engaged in other business ventures resulting in conflicts of interest.
• Certain remedies may be limited to the Company.
• Past performance is not indicative of future results.
• Changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters could significantly affect the Companys reported financial results or financial condition.

Future Outlook

The California legal cannabis market for 2025 may exceed USD 6.5 billion (which implies continued growth in downstream demand for concentrates).

Management Comments

• Micah Anderson, CEO of LEEF commented, I am incredibly excited to be taking LEEF into the next stage of its development and together with our new partners at Icanic. We look forward to continuing to build significant shareholder value for many years to come.
• Brandon Kou, CEO of Icanic Brands: This marriage will allow us to accomplish our collective goals quicker and I am proud to say that the combined teams have already been hard at work analyzing the synergies and identifying efficiencies allowing us to build towards a singular infrastructure.

Industry Context

The legal cannabis industry emerged as a response to growing public support for medical and adult-use legalization, along with recognition of its economic potential. The transition from prohibition to regulation has occurred in phases, primarily through state-level reforms.

Comparison to Industry Standards

• According to the California Cannabis Market Outlook, 2024 Report (commissioned by the California Department Cannabis Control), the regulated (licensed) cannabis segment continues to supply approximately 40 % of the total cannabis consumption in California, with the balance met by unlicensed sources.
• Industry sources estimate that Californias legal cannabis retail market in 2024 approached USD $4.66 billion.
• A third-party market research provider (Stellar MR) estimates that in 2024, flowers accounted for ~57 % of market value, with concentrates ~42 %.

Related Party Transactions

• The Company has relied on related parties for debt based funding of its operations.

Stakeholder Impact

• Shareholders may experience substantial dilution if the company seeks additional capital through a combination of public and private equity offerings and debt financings.
• The company's inability to raise financing to fund capital expenditures or acquisitions could limit its growth and may have a material adverse effect upon future profitability.

Next Steps

• Full-scale cultivation is anticipated to reach 187 acres by 2027.
• The Company has begun limited production in New York and expects to continue to scale operations over the coming months.

Key Dates

Recommendation

Given the company's net losses, volatile stock price, limited trading market, and the numerous risks associated with the cannabis industry, a sell recommendation is appropriate. The potential for dilution from future capital raises and the lack of dividends further support this recommendation.

Keywords

cannabis, extraction, manufacturing, concentrates, S-1, resale, LEEEF, LEEF Brands, filing